Aurora Sheboygan Pricing: Trastuzumab Therapy 150 mg Intravenous Solution at $474.40

Trastuzumab Therapy is a targeted cancer treatment commonly used for HER2-positive breast cancer and certain other cancers. At Aurora Medical Center Sheboygan County, a 150 mg intravenous dose of Trastuzumab is priced at $474.40. This fee typically covers the medication itself and may include the cost of preparation, but not always the administration, facility, or additional supportive care fees. Patients considering this treatment should request a fully itemized estimate—covering drug, infusion services, monitoring, and potential pre-medications—to understand their total financial responsibility and to prepare for possible additional charges.

Cost Breakdown

• Trastuzumab Drug (150 mg IV): $474.40 per dose
• Potential Additional Costs:
  • Infusion administration fee
  • Pre-treatment labs or imaging
  • Other medications (e.g., anti-nausea drugs)
  • Physician or nursing services
  • Follow-up monitoring or side-effect management

Insurance & Payment Advice

• Contact your insurance provider to confirm coverage for Trastuzumab Therapy, including drug and infusion services.
• Check if prior authorization is required to avoid claim denial.
• Ask about co-pays, deductibles, and out-of-pocket maximums related to this therapy.
• Inquire about financial assistance or payment plans if you are uninsured or underinsured.

Side Effect and Recovery Considerations

• Common side effects may include fever, nausea, headache, or infusion reactions. Inform your care team about any concerning symptoms.
• Some patients may need to remain for observation after infusion to monitor for adverse reactions.
• Arrange for transportation if you expect fatigue or other side effects post-treatment.

Frequently Asked Questions

• What is Trastuzumab Therapy used for?
  Trastuzumab is primarily used to treat HER2-positive breast cancer and some other HER2-positive cancers.
• Does the $474.40 fee include the cost of the infusion procedure?
  No, this fee typically covers only the Trastuzumab drug. Infusion administration and related services may be billed separately.
• How often will I need to receive Trastuzumab Therapy?
  The frequency depends on your specific cancer type and treatment plan. Many patients receive infusions every 1 to 3 weeks.
• Will my insurance cover Trastuzumab Therapy?
  Most insurance plans cover Trastuzumab for approved indications, but coverage details and out-of-pocket costs vary. Confirm with your insurer before treatment.
• Are there financial assistance programs for Trastuzumab?
  Many hospitals and pharmaceutical manufacturers offer assistance programs. Ask your care team or financial counselor for guidance.
• What if I experience side effects from Trastuzumab?
  Report any side effects to your oncology team promptly. They can offer supportive care or adjust your treatment if needed.
• Can I get an itemized estimate for the full cost of treatment?
  Yes, request an itemized estimate from the billing department to clarify all expected charges, including drug, infusion, and supportive care.
• Is there a difference between Trastuzumab and biosimilars?
  Biosimilars are highly similar versions of Trastuzumab that offer the same clinical benefits and may be less expensive. Ask if a biosimilar is available for your treatment.
• How long does a Trastuzumab infusion take?
  The initial infusion may take up to 90 minutes; subsequent doses are often administered over 30 to 60 minutes, depending on tolerance.
• Do I need to prepare in any way before my infusion appointment?
  Your care team may advise you about eating, drinking, or medications before the appointment. Always follow their instructions.
• What happens if I miss a scheduled dose?
  Contact your provider promptly to reschedule. Delays can affect treatment outcomes, so timely communication is important.

Aurora Medical Center Sheboygan County offers a range of medical services, including specialized cancer treatments. One such service is the administration of Trastuzumab Therapy, specifically a 150 mg intravenous solution priced at $474.40. Trastuzumab, often used in the treatment of certain types of breast cancer, is a monoclonal antibody that targets the HER2 protein, which can promote the growth of cancer cells. The cost of $474.40 reflects the price for a single dose of the Trastuzumab-anns 150 mg IV solution at Aurora Sheboygan, highlighting the center’s commitment to providing advanced cancer therapies to patients in the region.

What is Trastuzumab Therapy? – Trastuzumab Therapy is a targeted cancer treatment that uses a monoclonal antibody to interfere with the HER2 protein, which can promote the growth of cancer cells, particularly in certain types of breast cancer.

How is Trastuzumab administered? – Trastuzumab is administered as an intravenous solution, meaning it is delivered directly into the bloodstream through an IV, allowing for rapid absorption and effectiveness.

What is the cost of Trastuzumab Therapy at Aurora Medical Center Sheboygan County? – The cost for a 150 mg intravenous solution of Trastuzumab-anns at Aurora Medical Center Sheboygan County is $474.40.

Who is eligible for Trastuzumab Therapy? – Eligibility for Trastuzumab Therapy is typically determined by a healthcare provider based on the presence of the HER2 protein in the patient’s cancer cells and other individual health factors.

Are there any side effects associated with Trastuzumab Therapy? – Yes, like many cancer treatments, Trastuzumab Therapy can have side effects, which may include fever, chills, nausea, headache, and more serious effects like heart problems, which should be monitored by a healthcare provider.

How effective is Trastuzumab Therapy? – Trastuzumab Therapy has been shown to be effective in improving survival rates and reducing the risk of cancer recurrence in patients with HER2-positive breast cancer, though individual results may vary.

Can Trastuzumab Therapy be combined with other treatments? – Yes, Trastuzumab is often used in combination with other cancer treatments, such as chemotherapy, to enhance its effectiveness, but this should be determined by a healthcare provider based on the patient’s specific case.